532 related articles for article (PubMed ID: 34762280)
21. Paraquat exposure induces Parkinsonism by altering lipid profile and evoking neuroinflammation in the midbrain.
Tong T; Duan W; Xu Y; Hong H; Xu J; Fu G; Wang X; Yang L; Deng P; Zhang J; He H; Mao G; Lu Y; Lin X; Yu Z; Pi H; Cheng Y; Xu S; Zhou Z
Environ Int; 2022 Nov; 169():107512. PubMed ID: 36108500
[TBL] [Abstract][Full Text] [Related]
22. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.
Gordon R; Albornoz EA; Christie DC; Langley MR; Kumar V; Mantovani S; Robertson AAB; Butler MS; Rowe DB; O'Neill LA; Kanthasamy AG; Schroder K; Cooper MA; Woodruff TM
Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381407
[TBL] [Abstract][Full Text] [Related]
23. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration.
Qin L; Liu Y; Hong JS; Crews FT
Glia; 2013 Jun; 61(6):855-68. PubMed ID: 23536230
[TBL] [Abstract][Full Text] [Related]
24. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
[TBL] [Abstract][Full Text] [Related]
25. Synphilin-1 isoforms in Parkinson's disease: regulation by phosphorylation and ubiquitylation.
Szargel R; Rott R; Engelender S
Cell Mol Life Sci; 2008 Jan; 65(1):80-8. PubMed ID: 17982729
[TBL] [Abstract][Full Text] [Related]
26. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats.
Cicchetti F; Lapointe N; Roberge-Tremblay A; Saint-Pierre M; Jimenez L; Ficke BW; Gross RE
Neurobiol Dis; 2005 Nov; 20(2):360-71. PubMed ID: 16242641
[TBL] [Abstract][Full Text] [Related]
27. Unilateral intranigral administration of β-sitosterol β-D-glucoside triggers pathological α-synuclein spreading and bilateral nigrostriatal dopaminergic neurodegeneration in the rat.
Soto-Rojas LO; Martínez-Dávila IA; Luna-Herrera C; Gutierrez-Castillo ME; Lopez-Salas FE; Gatica-Garcia B; Soto-Rodriguez G; Bringas Tobon ME; Flores G; Padilla-Viveros A; Bañuelos C; Blanco-Alvarez VM; Dávila-Ayala J; Reyes-Corona D; Garcés-Ramírez L; Hidalgo-Alegria O; De La Cruz-López F; Martinez-Fong D
Acta Neuropathol Commun; 2020 Apr; 8(1):56. PubMed ID: 32321590
[TBL] [Abstract][Full Text] [Related]
28. Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation.
Hou L; Zhang C; Wang K; Liu X; Wang H; Che Y; Sun F; Zhou X; Zhao X; Wang Q
Toxicology; 2017 Apr; 380():1-10. PubMed ID: 28202386
[TBL] [Abstract][Full Text] [Related]
29. Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.
Kumar A; Leinisch F; Kadiiska MB; Corbett J; Mason RP
Mol Neurobiol; 2016 Jul; 53(5):2983-2994. PubMed ID: 25952542
[TBL] [Abstract][Full Text] [Related]
30. Postnatal zinc or paraquat administration increases paraquat or zinc-induced loss of dopaminergic neurons: insight into augmented neurodegeneration.
Mittra N; Chauhan AK; Singh G; Patel DK; Singh C
Mol Cell Biochem; 2020 Apr; 467(1-2):27-43. PubMed ID: 32060784
[TBL] [Abstract][Full Text] [Related]
31. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
Thiruchelvam M; Richfield EK; Baggs RB; Tank AW; Cory-Slechta DA
J Neurosci; 2000 Dec; 20(24):9207-14. PubMed ID: 11124998
[TBL] [Abstract][Full Text] [Related]
32. NADPH oxidase 1 mediates α-synucleinopathy in Parkinson's disease.
Cristóvão AC; Guhathakurta S; Bok E; Je G; Yoo SD; Choi DH; Kim YS
J Neurosci; 2012 Oct; 32(42):14465-77. PubMed ID: 23077033
[TBL] [Abstract][Full Text] [Related]
33. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS
Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration.
Mangano EN; Hayley S
Neurobiol Aging; 2009 Sep; 30(9):1361-78. PubMed ID: 18187236
[TBL] [Abstract][Full Text] [Related]
35. Chronic dichlorvos exposure: microglial activation, proinflammatory cytokines and damage to nigrostriatal dopaminergic system.
Binukumar BK; Bal A; Gill KD
Neuromolecular Med; 2011 Dec; 13(4):251-65. PubMed ID: 21964614
[TBL] [Abstract][Full Text] [Related]
36. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain.
Thakur P; Breger LS; Lundblad M; Wan OW; Mattsson B; Luk KC; Lee VMY; Trojanowski JQ; Björklund A
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8284-E8293. PubMed ID: 28900002
[TBL] [Abstract][Full Text] [Related]
37. Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo.
Bok E; Chung YC; Kim KS; Baik HH; Shin WH; Jin BK
Exp Mol Med; 2018 Jul; 50(7):1-14. PubMed ID: 29968707
[TBL] [Abstract][Full Text] [Related]
38. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
39. Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson's models.
La Vitola P; Balducci C; Baroni M; Artioli L; Santamaria G; Castiglioni M; Cerovic M; Colombo L; Caldinelli L; Pollegioni L; Forloni G
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):43-60. PubMed ID: 32696999
[TBL] [Abstract][Full Text] [Related]
40. Paraquat as an Environmental Risk Factor in Parkinson's Disease Accelerates Age-Related Degeneration Via Rapid Influx of Extracellular Zn
Tamano H; Nishio R; Morioka H; Furuhata R; Komata Y; Takeda A
Mol Neurobiol; 2019 Nov; 56(11):7789-7799. PubMed ID: 31119555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
